James M McKim, PhD

Research Associate Professor, Department of Biomedical Sciences

Primary Address
Business
IONTOX
4717 Campus Drive
Kalamazoo, MI, United States 49008

Biography

James McKim, PhD, is founder and president of IONTOX, a biotechnology company founded in 2014 dedicated to providing expertise to the area of in vitro toxicology, with a mission to build improved methods for predicting human adverse effects from chemical exposure. IONTOX offers advanced in vitro solutions that promise to increase the reliability of in vitro toxicology. This in-turn will reduce animal usage, improve the success of new drug candidates, and provide an advanced method of understanding systemic toxicity.

Dr. McKim is a graduate of Florida Technical College in Orlando, Florida. He earned his doctorate in biochemical and molecular toxicology from Oregon State University in Corvallis, Oregon, and also completed a postdoctoral fellowship in cellular and molecular toxicology with University of Kansas Medical Center in Kansas City, Kansas. Prior to founding IONTOX, he was founder, president, and CEO for CeeTox, and a senior research advisor with Pharmacia, serving as group leader for predictive toxicology.

Education

Postdoctoral Fellowship 1992, Cellular and Molecular Toxicology, Medical Center, University of Kansas
PhD 1989, Biochemical and Molecular Toxicology, Oregon State University
PhD 1989, Biochemical and Molecular Toxicology, Oregon State University
AS 1982, Ocean Engineering, Florida Technical College
BS 1982, Environmental Science, Florida Technical College
AS 1982, Ocean Engineering, Florida Technical College
BS 1982, Environmental Science, Florida Technical College